ClinicalTrials.Veeva

Menu

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status

Terminated

Conditions

Brain Tumor

Treatments

Procedure: FLT-PET scan

Study type

Observational

Funder types

Other

Identifiers

NCT00775320
FLT- Brain Study

Details and patient eligibility

About

The primary objective of this study is to detect and quantify tumor cells of high grade malignant gliomas and metastatic brain lesions both before and after initial surgical resection in a cohort of newly diagnosed patients.

Full description

In this study, 35 patients will be selected to undergoing sequential imaging with FLT-PET. Prior to surgical resection, patients will undergo a preliminary FLT-PET. Additional FLT scans for a maximum of four scans.

Enrollment

13 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older
  • Women must not be pregnant or breast feeding
  • Histologic or strong radiologic suspicion of high grade malignant glioma or ogliometastatic tumor(s)

Exclusion criteria

  • May not have received previous therapy for their malignancy

Trial design

13 participants in 1 patient group

Brain tumor FLT-PET
Description:
Those diagnosed with a brain tumor and are to undergo surgery
Treatment:
Procedure: FLT-PET scan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems